Aehr Test Systems (NASDAQ:AEHR) finished Wednesday with an addition of $1.2 to close at $20.46, an upside of 6.23 percent. An average of 8,397,080 shares of common stock have been traded in the last five days. There was a gain of $6.85 in the past week. The last 20 days have seen an average of 7,286,030 shares traded, while the 50-day average volume stands at 4,552,886.
AEHR stock has increased by 84.99% in the last month. The company shares reached their 1-month lowest point of $10.11 on 09/20/21. With the stock rallying to its 52-week high on 10/13/21, shares of the company touched a low of $1.15 and a high of $20.33 in 52 weeks. In spite of this, the price is up 0.64% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
3 days have passed since Aehr Test Systems (AEHR) last reported insider trading activity. Brannan Michael A., who is V.P. of Operations, most recently acquired $17,000 shares at $18.80 per share on Oct 11. In this transaction, the insider spent $319,600. Director, POSEDEL RHEA J, disposed of 24,000 shares at a price of $19.93 on Oct 11. The insider now owns more than $478,320 worth of shares. Prior to that, Director POSEDEL RHEA J went on to Sale 1,000 shares at $19.90 each on Oct 08. An amount of $19,900 was transacted.
Aehr Test Systems (AEHR) has a trailing price-to-earnings (P/E) ratio of 31.10 for the broader industry and 37.24 for the sector. In the last five years, Aehr Test Systems’s PE ratio has ranged between 444.03 and 97.58. The stock’s beta is 1.06. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 21.25, the price-to-book (PB) ratio at 42.62.
The quick ratio of Aehr Test Systems for the three months ended August 30 was 1.10, and the current ratio was 2.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.27 for the quarter ending August 30. On the profitability front, the trailing 12-month gross margin is 40.00% against a 5-year average of 37.6%. Aehr Test Systems’s EBITDA margin for the year ending August 30 is -23.33%, while its operating margin for the same period stands at -26.60%. Its gross profit as reported stood at $6.03 million compared to revenue of $16.6 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Aehr Test Systems’s return on assets was -28.70%, compared to -13.8% over the last five years. In the past year, the return on investment has been -12.50%, and the 5-year average is -18.0%. Meanwhile, the return on equity (ROE) for the past 12 months has been -48.70% and the 5-year average holds at -26.4%. For the broader industry, ROE averaged -0.25 over the past year.
The analyst consensus anticipated Aehr Test Systems’s latest quarter earnings to come in at -$0.03 per share, but it turned out to be -$0.02, a 33.30% surprise. For the quarter, EBITDA amounted to $0.67 million. Shareholders own equity worth $24.17 million.
From a technical analysis perspective, let’s take a brief look at Aehr Test Systems (AEHR) price momentum. RSI 9-day as of the close on 13 October was 79.77%, suggesting the stock is Overbought, with historical volatility in this time frame at 126.19%.
As of today, AEHR’s price is $19.14 +50.33% or $6.85 from its 5-day moving average. AEHR is currently trading +89.27% higher than its 20-day SMA and +847.22% higher than its 100-day SMA. However, the stock’s current price level is +260.85% above the SMA50 and +731.71% above the SMA200.
The stochastic %K and %D were 91.13% and 93.26%, respectively, and the average true range (ATR) was 1.90. With the 14-day stochastic at 90.51% and the average true range at 1.71, the RSI (14) stands at 77.30%. The stock has reached 3.34 on the 9-day MACD Oscillator while the 14-day reading was at 4.04.
The consensus rating for Aehr Test Systems (AEHR) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AEHR, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is AEHR’s price target for the next 12 months?
Analysts predict a range of price targets between $31.00 and $31.00, with a median target of $31.00. Taking a look at these predictions, the average price target given by analysts for Aehr Test Systems (AEHR) stock is $31.00.